CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.12% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Trade Sartorius Stedim Biotech SA - DIM CFD

207.59
1.86%
Market Trading Hours* (UTC) Open now
Closes on Wednesday at 16:30

Mon - Fri: 08:00 - 16:30

  • Summary
  • Historical Data
Trading сonditions
Spread 0.62
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.019346 %
Charges from full value of position ($-3.68)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.019346%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.002876 %
Charges from full value of position ($-0.55)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.002876%
Overnight fee time 22:00 (UTC)
Min traded quantity 0.1
Currency EUR
Margin 5.00%
Stock exchange France
Commission on trade 0%

Key Stats
Prev. Close 203.79
Open 203.69
1-Year Change -7.76%
Day's Range 203.69 - 207.89
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jan 21, 2025 203.79 4.45 2.23% 199.34 204.89 196.95
Jan 20, 2025 199.60 6.40 3.31% 193.20 200.39 192.70
Jan 17, 2025 196.80 1.35 0.69% 195.45 199.99 190.85
Jan 16, 2025 198.50 -3.79 -1.87% 202.29 203.49 196.10
Jan 15, 2025 200.09 2.64 1.34% 197.45 205.09 197.45
Jan 14, 2025 200.39 -5.60 -2.72% 205.99 208.79 199.54
Jan 13, 2025 201.69 3.50 1.77% 198.19 204.39 197.25
Jan 10, 2025 199.15 3.95 2.02% 195.20 201.89 195.20
Jan 9, 2025 199.74 5.14 2.64% 194.60 202.49 194.60
Jan 8, 2025 196.60 -1.20 -0.61% 197.80 199.99 194.25
Jan 7, 2025 197.40 6.50 3.40% 190.90 200.49 190.90
Jan 6, 2025 192.35 10.34 5.68% 182.01 193.05 182.01
Jan 3, 2025 181.66 0.30 0.17% 181.36 186.11 179.27
Jan 2, 2025 186.26 -1.30 -0.69% 187.56 188.31 184.36
Dec 31, 2024 187.41 3.40 1.85% 184.01 187.61 184.01
Dec 30, 2024 183.76 -2.40 -1.29% 186.16 186.96 182.86
Dec 27, 2024 187.16 5.70 3.14% 181.46 188.46 181.46
Dec 24, 2024 185.41 0.25 0.14% 185.16 187.06 184.96
Dec 23, 2024 185.21 3.85 2.12% 181.36 186.01 181.36
Dec 20, 2024 185.71 4.35 2.40% 181.36 186.71 181.11

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Sartorius Stedim Biotech Company profile

About Sartorius Stedim Biotech SA

Sartorius Stedim Biotech SA is a France-based international provider of laboratory and process technologies and equipment. The Company covers the segments of biotechnology and mechatronics. Sartorius provides services which help customers to implement complex and quality-critical processes in biopharmaceutical production and laboratory environments in a time- and cost-efficient way. The Company’s customers are from the biotech, pharma and food industries, as well as from public research institutes and laboratories. Sartorius operates its own production facilities in Europe, Asia and America, and also has sales offices and local representatives in more than 110 countries. The Company operates through its subsidiaries, including Sartorius Stedim Austria GmbH, Sartorius Stedim Plastics GmbH, BioOutsource Ltd and Wave Biotech AG, among others.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Sartorius Stedim Biotech SA revenues increased 51% to EUR2.89B. Net income applicable to common stockholders increased 23% to EUR414.4M. Revenues reflect EMEA segment increase of 60% to EUR829.1M, United States segment increase of 41% to EUR895.3M. Net income was partially offset by Financial Expense - Balancing value decrease from EUR1K (income) to EUR212.3M (expense).

Equity composition

07/2007, Company name changed from Stedim S.A. 05/2016, Scrip Issue, (Factor:5.99988).

Industry: Medical Equipment, Supplies & Distribution (NEC)

Zone Industrielle les Paluds Avenue de Jouques
Bp 1051
AUBAGNE
PACA 13781
FR

People also watch

US100

21,736.00 Price
+0.480% 1D Chg, %
Long position overnight fee -0.0233%
Short position overnight fee 0.0011%
Overnight fee time 22:00 (UTC)
Spread 1.8

Gold

2,761.55 Price
+0.580% 1D Chg, %
Long position overnight fee 0.0110%
Short position overnight fee -0.0193%
Overnight fee time 22:00 (UTC)
Spread 0.30

BTC/USD

104,920.30 Price
-1.880% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

XRP/USD

3.16 Price
-1.040% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01578

Still looking for a broker you can trust?

Join the 680,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading